Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angelo Restuccia"'
Autor:
Nicola Basso, Paolo Gentileschi, Carlo Catalano, Michel Gagner, Angelo Restuccia, Gianfranco Silecchia, Ugo Elmore
Publikováno v:
Obesity Surgery. 12:39-48
Background: After open or laparoscopic Roux-en-Y gastric bypass (RYGBP) for morbid obesity, the bypassed stomach and duodenum are not readily available for radiological and endoscopic evaluation. Furthermore, little is known about the long-term physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357acb5537aa9ad1f28cd6fa030774d1
https://doi.org/10.1381/096089202321144568
https://doi.org/10.1381/096089202321144568
Autor:
Antonello Bucci, Angelo Restuccia, Francesco Greco, Nicola Perrotta, Vincenzo Bacci, Maria Sole Basso, Ugo Elmore, Gianfranco Silecchia, Romina Lamberti
Publikováno v:
Obesity surgery. 12(1)
Background: The well-known inverse relation between life expectancy and BMI, particularly in morbid obesity, is presumably in large part due to multiple cardiovascular and metabolic comorbidities. Severely obese patients treated with laparoscopic adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d543b1caa8d06f63b289c2a1047616f9
https://pubmed.ncbi.nlm.nih.gov/11868304
https://pubmed.ncbi.nlm.nih.gov/11868304
Autor:
Nicola Perrotta, Alfredo Genco, Angelo Restuccia, Nicola Basso, Vincenzo Bacci, Gianfranco Silecchia, Domenico Polito, Ugo Elmore
Intragastric prosthesis (Lap-Band, BioEnterics Co., Carpinteria, CA, U.S.A.) migration is one of the major long-term complications of laparoscopic adjustable silicone gastric banding. The causes, clinical signs, timing, and overall incidence of band
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f44e57a3a3750ea8b0cef2ee1ea3e5
http://hdl.handle.net/11573/385709
http://hdl.handle.net/11573/385709
Autor:
Pasquale Pierimarchi, Cynthia Tuthill, Gianfranco Silecchia, Angelo Restuccia, Guido Rasi, Paola Sinibaldi-Vallebona, Enrico Garaci, E. Guarino, Paola Bernard, Erasmo Spaziani
Publikováno v:
Cancer immunology and immunotherapy 48 (1999): 172–178.
info:cnr-pdr/source/autori:Silecchia G, Guarino E, Sinibaldi-Vallebona P*, Pierimarchi P*, Restuccia A, Spaziani E, Bernard P*, Tuthill C, Garaci E, Rasi G*./titolo:Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery./doi:/rivista:Cancer immunology and immunotherapy/anno:1999/pagina_da:172/pagina_a:178/intervallo_pagine:172–178/volume:48
info:cnr-pdr/source/autori:Silecchia G, Guarino E, Sinibaldi-Vallebona P*, Pierimarchi P*, Restuccia A, Spaziani E, Bernard P*, Tuthill C, Garaci E, Rasi G*./titolo:Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery./doi:/rivista:Cancer immunology and immunotherapy/anno:1999/pagina_da:172/pagina_a:178/intervallo_pagine:172–178/volume:48
We have used chemo-immunotherapy with 5-fluorouracil (5-FU), thymosin alpha1 (T alpha1) and interleukin-2 (IL-2) to treat multiple liver metastases from colorectal cancer induced by DHD/K12 cells in syngeneic BDIX rats, comparing one and two cycles o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea849f4bb2bf5cc64a09ff485cfc85d
http://www.cnr.it/prodotto/i/197114
http://www.cnr.it/prodotto/i/197114